Discovery of breast cancers within 1 year of a normal screening mammogram: How are they found?

Annals of Family Medicine

Volumn 4, Issue 6, 2006, Pages 512-518

  Carney, Patricia A ^a,b   Steiner, Elizabeth ^b   Goodrich, Martha E ^a   Dietrich, Allen J ^a   Kasales, Claudia J ^a   Weiss, Julia E ^a   MacKenzie, Todd ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Breast neoplasms; Community health; Health care seeking behavior; Mammography screening; Public health; Signs; Surveillance; Symptoms

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER SCREENING; CLINICAL EXAMINATION; FAMILY HISTORY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PHYSICIAN; PRIMARY MEDICAL CARE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OFFICE VISITS; PRIMARY HEALTH CARE; SOCIOECONOMIC FACTORS; TIME FACTORS; ULTRASONOGRAPHY, MAMMARY;

EID: 33845499045     PISSN: 15441709     EISSN: 15441717     Source Type: Journal    
DOI: 10.1370/afm.580     Document Type: Article

References (21)

1. Cowan WK, Angus B, Gray JC, Lunt LG, al-Tamimi SR. A study of interval breast cancer within the NHS Breast Screening Programme. J Clin Pathol. 2000;53:140-146.
2. DeGroote R, Rush BF Jr, Milazzo J, Warden MJ, Rocko JM. Interval breast cancer: a more aggressive subset of breast neoplasias. Surgery. 1983;94:543-547.
3. Gilliland FD, Joste N, Stauber PM, et al. Biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst. 2000;92:743-749.
4. Taplin SH, Rutter CM, Finder C, et al. Screening mammography: clinical image quality and the risk of interval breast cancer. AJR Am J Roentgenol. 2002;178:797-803.
5. de Rijke JM, Schouten LJ, Schreutelkamp JL, Jochem I, Verbeek AL. A blind review and an informed review of interval breast cancer cases in the Limburg screening programme, the Netherlands. J Med Screen. 2000;7:19-23.
6. Britton PD, McCann J, O'Driscoll D, Hunnam G, Warren RM. Interval cancer peer review in East Anglia: implications for monitoring doctors as well as the NHS Breast Screening Programme. Clin Radiol. 2001;56:44-49.
7. Morrone D, Giorgi D, Ciatto S, et al. Radiologic analysis of interval cancers in the screening program called Florence Woman Project [in Italian]. Radiol Med (Torino). 2000;100:321-325.
8. Vitak B, Olsen KE, Manson JC, Arnesson LG, Stal O. Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers. Eur Radiol. 1999;9:460-469.
9. Poplack SP, Tosteson AN, Grove MR, Wells WA, Carney PA. Mammography in 53,803 women from the New Hampshire Mammography Network. Radiology. 2000;217:832-840.
10. Kerlikowske K, Carney PA, Geller B, et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med. 2000;133:855-863.
11. US Department of Health and Human Services. Agency for Healthcare Research and Quality. US Preventive Services Task Force. Screening for breast cancer. 2002. Available at: http://www.ahrq. gov/clinic/uspstf/uspsbrca.htm. Accessed 29 September 2006.
12. Carney PA, Poplack SP, Wells WA, Littenberg B. The New Hampshire Mammography Network: the development and design of a population-based registry. AJR Am J Roentgenol. 1996;167:367-372.
13. The American College of Radiology Breast Imaging and Reporting Data System (BI-RADS). 3rd ed. Reston, Va: American College of Radiology; 1998.
14. Conover WJ. Fisher's exact, most nonparametric. In: Practical Nonparametric Statistics. 2nd ed. New York, NY: John Wiley and Sons; 1980.
15. McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res. 2002;4:R11.
16. Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey. West J Med. 2000;173:307-312.
17. Elmore JG, Reisch LM, Barton MB, et al. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst. 2005;97:1035-1043.
18. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168-175.
19. Leung W, Goldberg F, Zee B, Sterns E. Mammographic density in women on postmenopausal hormone replacement therapy. Surgery. 1997;122:669-673; discussion 673-674.
20. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol. 1997;15:3201-3207.
21. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA. 2001;285:171-176.